| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |